Leaderboards/bladder and urothelial cancer treatments

bladder and urothelial cancer treatments

Last updated June 11, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Antoine G. van der Heijden
Radboud University Nijmegen
99
2
Michael Rink
Marienkrankenhaus Hamburg
90
3
Andrea B. Apolo
National Institutes of Health
80
4
Amir Mortazavi
The Ohio State University
70
5
Feng Wen
Sichuan University
60
6
Yali Shen
Sichuan University
50
7
Piotr J. Wysocki
Jagiellonian University
40
8
Robert L. Hudkins
State Street (United States)
30
9
Daniel C. Bensen
State Street (United States)
20
10
Vicky Makker
Memorial Sloan Kettering Cancer Center
10

Rising Stars Papers

Insufficient data

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Thomas Powles
Queen Mary University of London
99
2
Niklas Klümper
University Hospital Bonn
90
3
Thomas W. Flaig
University of Colorado Cancer Center
80
4
Richard Cathomas
Kantonsspital Graubünden
70
5
Savio Domenico Pandolfo
University of L'Aquila
50
6
Iver Nordentoft
Aarhus University Hospital
40
7
Minas P. Economides
New York University
20

Emerging Leaders Papers

1
Preclinical evidence for the use of <scp>anti‐Trop</scp> ‐2 antibody‐drug conjugate Sacituzumab govitecan in cerebral metastasized castration‐resistant prostate cancer
Cancer Medicine|2024
9 cit.

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Nicholas J. Vogelzang
Comprehensive Cancer Centers of Nevada
99
2
Neil H. Segal
Institut Gustave Roussy
90
3
Shahrokh F. Shariat
The University of Texas Southwestern Medical Center
80
4
Lars Dyrskjøt
Aarhus University Hospital
70
5
Andrew W. Bruce
Queen's University
60
6
Christian Pfister
Inserm
60
7
Keith Syson Chan
Baylor College of Medicine
50
8
Daniel Castellano
Research Institute Hospital 12 de Octubre
40
9
Petros Grivas
Cancer Research Center
30
10
Johan Björklund
Karolinska University Hospital
30

All-Time Leaders Papers

1
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
Nature Communications|2021
374 cit.
2
Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis
Journal of Clinical Investigation|2004
310 cit.
3
Multicenter Validation of Cyclin D1, MCM7, TRIM29, and UBE2C as Prognostic Protein Markers in Non-Muscle–Invasive Bladder Cancer
American Journal Of Pathology|2012
77 cit.
4
Low ANXA10 expression is associated with disease aggressiveness in bladder cancer
British Journal of Cancer|2011
47 cit.
5
Collagen-rich airway smooth muscle cells are a metastatic niche for tumor colonization in the lung
Nature Communications|2019
47 cit.
6
Cell death-induced immunogenicity enhances chemoimmunotherapeutic response by converting immune-excluded into T-cell inflamed bladder tumors
Nature Communications|2022
47 cit.
7
High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression
BMC Cancer|2009
33 cit.
8
The SMARCD Family of SWI/SNF Accessory Proteins Is Involved in the Transcriptional Regulation of Androgen Receptor-Driven Genes and Plays a Role in Various Essential Processes of Prostate Cancer
Cells|2022
17 cit.
9
COLUMBIA-1: a randomised study of durvalumab plus oleclumab in combination with chemotherapy and bevacizumab in metastatic microsatellite-stable colorectal cancer
British Journal of Cancer|2024
12 cit.

Reagents for bladder and urothelial cancer treatments

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

Cell Signaling Technology

MEK1 (D2R1O) Rabbit Monoclonal Antibody

#12671$169
View Evidence →

⭐ Recommended

Best all-around

Cell Signaling Technology

Progesterone Receptor A/B (D8Q2J) Rabbit Monoclonal Antibody (BSA and Azide Free)

Cited in 5 papers
#18444$865
View Evidence →Cell Signaling Technology

Phospho-FoxM1 (Ser35) Antibody

Cited in 5 papers
#14170$362
View Evidence →Cell Signaling Technology

SH3BP4 (D3D9I) Rabbit Monoclonal Antibody

Cited in 5 papers
#55935$161
View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

ZFP36L1 (E6L6S) Rabbit Monoclonal Antibody

Cited in 7 papers
#30894$161
View Evidence →Cell Signaling Technology

MAML1 Antibody

Cited in 6 papers
#4608$317
View Evidence →Proteintech

anti-IL28a recombinant VHH, for 2x Cys conjugation

Cited in 5 papers
#IL28aCys2$709
View Evidence →